CIB researchers participate in the XX Farma-Biotech Cooperation Meeting

This Wednesday, April 28, the XX Farma-Biotech Cooperation Meeting was held. This event, organized by Farmaindustria together with the CSIC, seeks that pharmaceutical companies meet with research groups and Spanish biotechnology companies to reach cooperation agreements around the development of new drugs.

The conference was focused on the presentation of innovative projects developed by different CSIC research groups. The projects for the development of new pharmaceutical products have been selected according to the advanced state of their research and their great potential. Following this criterion, seven proposals have been presented with sufficient maturity to study cooperation agreements with the invited pharmaceutical companies.

The CIB Margarita Salas has been very present in this meeting, since four of the seven presentations are related, in one way or another, with the center.

Drs. Ana Martínez and Pedro García presented their projects, focused on CDC7 inhibitors with therapeutic potential in ALS and frontotemporal dementia and polypeptides with antibacterial activity, respectively. Drs. María José Sánchez (IQF) and Alicia Mansilla (IRYCIS, Hospital Ramón y Cajal) presented the project on synapse modulators targeting the NCS-1/Ric8a complex for the treatment of neurodegenerative disorders, for which Dr. Ruth Pérez is the principal investigator. And the biotechnology company Proalt with Dr. Juan Ignacio Imbaud, which presented a monoclonal antibody for the treatment of metastatic colorectal cancer, is a spin-off of the CSIC co-founded by Dr. Ignacio Casal and in close collaboration with him. Daniel López and Esteban Veiga (CNB) and José Martínez (IBB) have also presented their projects.

The event was held online and was closed to third parties in order to favor interaction between attendees, fostering the exchange of innovative information in the field of new therapies and advanced medicines.